Cureety acquires Reimagine Care to expand precision oncology platform

The acquisition combines Cureety's therapy-specific oncology monitoring platform with Reimagine Care's AI-enabled virtual cancer-care capabilities.
Cureety has acquired US-based Reimagine Care, creating a transatlantic precision-oncology platform supporting more than 250 cancer centres and approximately 100,000 patients across five countries.
The combined organisation brings together clinical monitoring and triage technology with AI-supported patient engagement and virtual oncology care, expanding the companies' ability to support patients between hospital visits.
Field | Content |
Alert Type | Deal |
Companies | Cureety; Reimagine Care |
Deal Type | Acquisition |
Asset or Company | Reimagine Care |
Therapy Area(s) | Oncology |
Technology or Modality | Digital health; AI-enabled virtual oncology care; remote patient monitoring |
Deal Value | Financial terms were not disclosed |
Geography | United States and Europe |
What Happened | Cureety acquired Reimagine Care, combining two digital oncology businesses focused on remote monitoring, patient engagement and virtual cancer care. |
Why It Matters | The transaction creates a larger precision-oncology platform supporting more than 250 cancer centres and around 100,000 patients across five countries. |
Supporting Context | Cureety provides therapy-specific monitoring and clinical triage technology, while Reimagine Care provides AI-supported patient engagement and virtual oncology services. |
Strategic Rationale | The acquisition combines complementary technology and care-delivery capabilities to support more continuous cancer care outside traditional clinical settings. |
Potential Impact | The enlarged platform could help oncology providers monitor more patients remotely, identify deterioration earlier and reduce administrative burden on care teams. |
Key Takeaway | Cureety's acquisition of Reimagine Care creates a scaled transatlantic digital oncology organisation serving more than 100,000 patients. |
What to Watch | Integration of Reimagine Care's AI and virtual-care capabilities into Cureety's platform and expansion across additional oncology providers. |
Primary Source | Cureety |
Relevant Date | 2 September 2026 |
Discover how nuaxia can support your next medical education initiative:
Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector
Contact us on: support@nuaxia.com



Kommentare